ProQR Therapeutics N.V Accounts Payable

ProQR Therapeutics N.V (PRQR) currently reports a accounts payable of $190K as of March 2026. That compares with $410K in the prior-year period — down 54.3% year over year. Use the charts on this page to explore ProQR Therapeutics N.V's accounts payable history and peer comparisons.

ProQR Therapeutics N.V's accounts payable decreased from $410K to $190K — a 54.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ProQR Therapeutics N.V reported $190K in accounts payable as of March 2026. That compares with $410K in the prior-year period — down 54.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $190K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ProQR Therapeutics N.V, and consider following PRQR for alerts when major investors trade the stock.

ProQR Therapeutics N.V is classified in the Healthcare sector. On accounts payable, it currently shows $190K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRQR with unrelated industries.